Literature DB >> 20386032

Teleradiology in an inaccessible area of northern India.

Amit Char1, Arjun Kalyanpur, V N Puttanna Gowda, Anjan Bharathi, Jasbir Singh.   

Abstract

Teleradiology can be used to provide health care to rural populations, especially where there is a scarcity of resources, including on-site radiologists. We have established a network link between a commercial teleradiology provider in Bangalore, south India and the Ramakrishna Mission Hospital (RKMH), located over 3000 km away in the north east of India. Image files were transferred to Bangalore via an ADSL connection using secure file transfer protocol. In the 12-month period beginning in August 2007, a total of 962 studies was sent to Bangalore from the RKMH. The average turnaround time for the report to reach the hospital once the images had been received in Bangalore was six hours for non-emergency cases. For emergency cases the turnaround time was consistently below 30 minutes. Because the RKMH was a charitable institution providing rural patients with free or low-cost treatment, no charge was made for the reporting. Our experience demonstrates that remote implementation of teleradiology is possible in rural India. The service has proved valuable for the remote hospital concerned.

Entities:  

Mesh:

Year:  2010        PMID: 20386032     DOI: 10.1258/jtt.2009.009007

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  2 in total

Review 1.  The Empirical Foundations of Teleradiology and Related Applications: A Review of the Evidence.

Authors:  Rashid L Bashshur; Elizabeth A Krupinski; James H Thrall; Noura Bashshur
Journal:  Telemed J E Health       Date:  2016-09-01       Impact factor: 3.536

2.  Fracture diagnostics, unnecessary travel and treatment: a comparative study before and after the introduction of teleradiology in a remote general practice.

Authors:  Jac J W M Jacobs; Jan P A M Jacobs; Eric van Sonderen; Thys van der Molen; Robbert Sanderman
Journal:  BMC Fam Pract       Date:  2015-05-06       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.